A low-cost technology to detect and monitor glaucoma in outpatient settings
smartOCT: a low-cost technology to detect and monitor glaucoma in outpatient and primary care centers
['FUNDING_R01'] · VANDERBILT UNIVERSITY · NIH-10796806
This study is working on a new, easy-to-use device called smartOCT that helps doctors quickly check for glaucoma, especially in places where people might not get regular eye care, so they can catch the condition early and protect your vision.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY (nih funded) |
| Locations | 1 site (Nashville, UNITED STATES) |
| Trial ID | NIH-10796806 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a low-cost and portable technology called smartOCT to detect and monitor glaucoma, a leading cause of irreversible vision loss. The approach aims to make glaucoma screening accessible in outpatient and primary care centers, particularly for underserved populations who may not have regular access to eye care. By utilizing optical coherence tomography (OCT), the research seeks to identify glaucoma in its early stages, allowing for timely intervention to prevent vision loss. The methodology emphasizes user-friendliness and portability to facilitate widespread use in various healthcare settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for glaucoma, particularly those from underserved communities with limited access to eye care.
Not a fit: Patients who are already receiving regular glaucoma screenings or those with advanced glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection and management of glaucoma, ultimately preserving vision for millions of patients.
How similar studies have performed: Other research has shown promise in using portable technologies for glaucoma detection, indicating that this approach could be effective.
Where this research is happening
Nashville, UNITED STATES
- VANDERBILT UNIVERSITY — Nashville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BOWDEN, AUDREY KYNSELLA — VANDERBILT UNIVERSITY
- Study coordinator: BOWDEN, AUDREY KYNSELLA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: diabetes, Diabetes Mellitus